{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:51Z","timestamp":1790845551879,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00394-019-01925-6","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T07:47:23Z","timestamp":1550130443000},"page":"557-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma"],"prefix":"10.1007","volume":"59","author":[{"given":"Melina","family":"Mitsiogianni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Mantso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios T.","family":"Trafalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Vasantha Rupasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Zoumpourlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Botaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aglaia","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihalis I.","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"1925_CR1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont AM, Spatz A, Robert C (2014) Cutaneous melanoma. Lancet 383:816\u2013827","journal-title":"Lancet"},{"key":"1925_CR2","first-page":"197","volume":"2","author":"AP Algazi","year":"2010","unstructured":"Algazi AP, Soon CW, Daud AI (2010) Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res 2:197\u2013211","journal-title":"Cancer Manag Res"},{"key":"1925_CR3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.7314\/APJCP.2013.14.3.1565","volume":"14","author":"AFA Razis","year":"2013","unstructured":"Razis AFA, Noor NM (2013) Cruciferous vegetables: dietary phytochemicals for cancer prevention. Asian Pacific J Cancer Prev 14:1565\u20131570","journal-title":"Asian Pacific J Cancer Prev"},{"key":"1925_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jff.2013.09.029","volume":"7","author":"D Angelino","year":"2014","unstructured":"Angelino D, Jeffery E (2014) Glucosinolate hydrolysis and bioavailability of resulting isothiocyanates: focus on glucoraphanin. J Funct Foods 7:67\u201376","journal-title":"J Funct Foods"},{"key":"1925_CR5","doi-asserted-by":"crossref","unstructured":"Wagner AE, Terschluesen AM, Rimbach G (2013) Health promoting effects of brassica-derived phytochemicals: from chemopreventive and anti-inflammatory activities to epigenetic regulation. Oxid Med Cell Longev 2013","DOI":"10.1155\/2013\/964539"},{"key":"1925_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2012.04.003","volume":"18","author":"AT Dinkova-Kostova","year":"2012","unstructured":"Dinkova-Kostova AT, Kostov RV (2012) Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 18:337\u2013347","journal-title":"Trends Mol Med"},{"key":"1925_CR7","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3892\/ijo.2012.1640","volume":"41","author":"SC Tsai","year":"2012","unstructured":"Tsai SC, Huang WW, Huang WC, Lu CC, Chiang JH, Peng SF et al (2012) ERK-modulated intrinsic signaling and G2\/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells. Int J Oncol 41:2065\u20132072","journal-title":"Int J Oncol"},{"key":"1925_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/or.2013.2865","volume":"31","author":"KC Lai","year":"2014","unstructured":"Lai KC, Lu CC, Tang YJ, Chiang JH, Kuo DH, Chen FA et al (2014) Allyl isothiocyanate inhibits cell metastasis through suppression of the MAPK pathways in epidermal growth factor\u2013stimulated HT29 human colorectal adenocarcinoma cells. Oncol Rep 31:189\u2013196","journal-title":"Oncol Rep"},{"key":"1925_CR9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/ijms17091530","volume":"17","author":"YM Cheng","year":"2016","unstructured":"Cheng YM, Tsai CC, Hsu YC (2016) Sulforaphane, a dietary isothiocyanate, induces G2\/M arrest in cervical cancer cells through cyclin B1 downregulation and GADD45\u03b2\/CDC2 association. Int J Mol Sci 17:1530","journal-title":"Int J Mol Sci"},{"key":"1925_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/carcin\/bgi251","volume":"27","author":"C Xu","year":"2006","unstructured":"Xu C, Shen G, Yuan X, Kim JH, Gopalkrishnan A, Keum YS et al (2006) ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27:437\u2013445","journal-title":"Carcinogenesis"},{"key":"1925_CR11","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.12659\/MSM.897315","volume":"22","author":"Z Jiang","year":"2016","unstructured":"Jiang Z, Liu X, Chang K, Liu X, Xiong J (2016) Allyl isothiocyanate inhibits the proliferation of renal carcinoma cell line GRC-1 by inducing an imbalance between Bcl2 and Bax. Med Sci Monit 22:4283\u20134288","journal-title":"Med Sci Monit"},{"key":"1925_CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0960327113491508","volume":"33","author":"S Huang","year":"2014","unstructured":"Huang S, Hsu M, Hsu S, Yang J, Huang W, Huang A et al (2014) Phenethyl isothiocyanate triggers apoptosis in human malignant melanoma A375. S2 cells through reactive oxygen species and the mitochondria-dependent pathways. Hum Exp Toxicol 33:270\u2013283","journal-title":"Hum Exp Toxicol"},{"key":"1925_CR13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/jf204193v","volume":"60","author":"SH Huang","year":"2012","unstructured":"Huang SH, Wu LW, Huang AC, Yu CC, Lien JC, Huang YP et al (2012) Benzyl isothiocyanate induces G2\/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species and both mitochondria-dependent and death receptor-mediated multiple signaling pathways. J Agric Food Chem 60:665\u2013675","journal-title":"J Agric Food Chem"},{"key":"1925_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08923970701511728","volume":"29","author":"P Thejass","year":"2007","unstructured":"Thejass P, Kuttan G (2007) Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL\/6 mice by sulforaphane. Immunopharmacol Immunotoxicol 29:173\u2013186","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1925_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.niox.2006.09.006","volume":"16","author":"P Thejass","year":"2007","unstructured":"Thejass P, Kuttan G (2007) Allyl isothiocyanate and phenyl isothiocyanate inhibit tumour-specific angiogenesis by downregulating nitric oxide and tumour necrosis factor-\u03b1 (TNF-\u03b1) production. Nitric Oxide 16:247\u2013257","journal-title":"Nitric Oxide"},{"key":"1925_CR16","doi-asserted-by":"crossref","first-page":"e86787","DOI":"10.1371\/journal.pone.0086787","volume":"9","author":"CP Wong","year":"2014","unstructured":"Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, Houseman EA et al (2014) Effects of sulforaphane and 3,3\u2032-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells. PLoS One 9:e86787","journal-title":"PLoS One"},{"key":"1925_CR17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jff.2015.07.002","volume":"18","author":"W Yuanfeng","year":"2015","unstructured":"Yuanfeng W, Gongnian X, Jianwei M, Shiwang L, Jun H, Lehe M (2015) Dietary sulforaphane inhibits histone deacetylase activity in B16 melanoma cells. J Funct Foods 18:182\u2013189","journal-title":"J Funct Foods"},{"key":"1925_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1940-6207.CAPR-13-0313-T","volume":"7","author":"ZY Su","year":"2014","unstructured":"Su ZY, Zhang C, Lee JH, Shu L, Wu TY, Khor TO et al (2014) Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane. Cancer Prev Res 7:319\u2013329","journal-title":"Cancer Prev Res"},{"key":"1925_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2016.10.021","volume":"114","author":"SS Boyanapalli","year":"2016","unstructured":"Boyanapalli SS, Li W, Fuentes F, Guo Y, Ramirez CN, Gonzalez XP et al (2016) Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells. Pharmacol Res 114:175\u2013184","journal-title":"Pharmacol Res"},{"key":"1925_CR20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bcp.2013.02.010","volume":"85","author":"C Zhang","year":"2013","unstructured":"Zhang C, Su ZY, Khor TO, Shu L, Kong AN (2013) Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem Pharmacol 85:1398\u20131404","journal-title":"Biochem Pharmacol"},{"key":"1925_CR21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4161\/epi.24710","volume":"8","author":"P Rajendran","year":"2013","unstructured":"Rajendran P, Kidane AI, Yu TW, Dashwood WM, Bisson WH, L\u00f6hr CV et al (2013) HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates. Epigenetics 8:612\u2013623","journal-title":"Epigenetics"},{"key":"1925_CR22","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.3390\/ijms12128661","volume":"12","author":"S Golbabapour","year":"2011","unstructured":"Golbabapour S, Abdulla MA, Hajrezaei MA (2011) Concise review on epigenetic regulation: insight into molecular mechanisms. Int J Mol Sci 12:8661\u20138694","journal-title":"Int J Mol Sci"},{"key":"1925_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","volume":"138","author":"Z Wang","year":"2009","unstructured":"Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W et al (2009) Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138:1019\u20131031","journal-title":"Cell"},{"key":"1925_CR24","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1128\/MCB.00311-06","volume":"26","author":"C Yan","year":"2006","unstructured":"Yan C, Boyd DD (2006) Histone H3 acetylation and H3K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol 26:6357\u20136371","journal-title":"Mol Cell Biol"},{"key":"1925_CR25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.molonc.2012.09.003","volume":"6","author":"M New","year":"2012","unstructured":"New M, Olzscha H, La Thangue NB (2012) HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol 6:637\u2013656","journal-title":"Mol Oncol"},{"key":"1925_CR26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124:30\u201339","journal-title":"J Clin Invest"},{"key":"1925_CR27","doi-asserted-by":"crossref","first-page":"371832","DOI":"10.1155\/2011\/371832","volume":"2011","author":"A Peserico","year":"2011","unstructured":"Peserico A, Simone C (2011) Physical and functional HAT\/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol 2011:371832","journal-title":"J Biomed Biotechnol"},{"key":"1925_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.02.045","volume":"562","author":"F Vahid","year":"2015","unstructured":"Vahid F, Zand H, Nosrat-Mirshekarlou E, Najafi R, Hekmatdoost A (2015) The role of bioactive compounds on the regulation of histone acetylases and deacetylases: a review. Gene 562:8\u201315","journal-title":"Gene"},{"key":"1925_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2010.09.004","volume":"12","author":"R Teperino","year":"2010","unstructured":"Teperino R, Schoonjans K, Auwerx J (2010) Histone methyltransferases and demethylases: can they link metabolism and transcription? Cell Metab 12:321\u2013327","journal-title":"Cell Metab"},{"key":"1925_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2009.11.009","volume":"386","author":"D Do","year":"2010","unstructured":"Do D, Pai S, Rizvi SA, D\u2019Souza MJ (2010) Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy. Int J Pharm 386:114\u2013121","journal-title":"Int J Pharm"},{"key":"1925_CR31","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/mc.22448","volume":"55","author":"ML Fisher","year":"2016","unstructured":"Fisher ML, Adhikary G, Grun D, Kaetzel DM, Eckert RL (2016) The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane. Mol Carcinog 55:2024\u20132036","journal-title":"Mol Carcinog"},{"key":"1925_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/01480545.2010.538694","volume":"34","author":"TP Hamsa","year":"2011","unstructured":"Hamsa TP, Thejass P, Kuttan G (2011) Induction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells. Drug Chem Toxicol 34:332\u2013340","journal-title":"Drug Chem Toxicol"},{"key":"1925_CR33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10495-013-0959-7","volume":"19","author":"K Rudolf","year":"2014","unstructured":"Rudolf K, Cervinka M, Rudolf E (2014) Sulforaphane-induced apoptosis involves p53 and p38 in melanoma cells. Apoptosis 19:734\u2013747","journal-title":"Apoptosis"},{"key":"1925_CR34","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00394-017-1527-7","volume":"57","author":"P Arcidiacono","year":"2018","unstructured":"Arcidiacono P, Ragonese F, Stabile A, Pistilli A, Kuligina E, Rende M et al (2018) Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells. Eur J Nutr 57:2547\u20132569","journal-title":"Eur J Nutr"},{"key":"1925_CR35","first-page":"6223","volume":"37","author":"YS Ma","year":"2017","unstructured":"Ma YS, Hsiao YT, Lin JJ, Liao CL, Lin CC, Chung JG (2017) Phenethyl isothiocyanate (PEITC) and benzyl isothiocyanate (BITC) inhibit human melanoma A375. S2 cell migration and invasion by affecting MAPK signaling pathway in vitro. Anticancer Res 37:6223\u20136234","journal-title":"Anticancer Res"},{"key":"1925_CR36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3892\/mmr.2015.3371","volume":"12","author":"RP Sahu","year":"2015","unstructured":"Sahu RP (2015) Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells. Mol Med Rep 12:394\u2013400","journal-title":"Mol Med Rep"},{"key":"1925_CR37","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.21873\/anticanres.11226","volume":"36","author":"T Mantso","year":"2016","unstructured":"Mantso T, Sfakianos AP, Atkinson A, Anestopoulos I, Mitsiogianni M, Botaitis S et al (2016) Development of a novel experimental in vitro model of isothiocyanate-induced apoptosis in human malignant melanoma cells. Anticancer Res 36:6303\u20136309","journal-title":"Anticancer Res"},{"key":"1925_CR38","first-page":"623","volume":"27","author":"WY Ni","year":"2013","unstructured":"Ni WY, Hsiao YP, Hsu SC, Hsueh SC, Chang CH, Ji BC et al (2013) Oral administration of benzyl-isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375. S2 cells. In Vivo 27:623\u2013626","journal-title":"In Vivo"},{"key":"1925_CR39","first-page":"891","volume":"28","author":"WY Ni","year":"2014","unstructured":"Ni WY, Lu HF, Hsu SC, Hsiao YP, Liu KC, Liu JY et al (2014) Phenethyl isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375.S2 cells. In Vivo 28:891\u2013894","journal-title":"In Vivo"},{"key":"1925_CR40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0367-326X(03)00055-8","volume":"74","author":"C Manesh","year":"2003","unstructured":"Manesh C, Kuttan G (2003) Effect of naturally occurring allyl and phenyl isothiocyanates in the inhibition of experimental pulmonary metastasis induced by B16F-10 melanoma cells. Fitoterapia 74:355\u2013363","journal-title":"Fitoterapia"},{"key":"1925_CR41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/0250-474X.156600","volume":"77","author":"P Bansal","year":"2015","unstructured":"Bansal P, Medhe S, Ganesh N, Srivastava MM (2015) Antimelanoma potential of eruca sativa seed oil and its bioactive principles. Indian J Pharm Sci 77:208\u2013217","journal-title":"Indian J Pharm Sci"},{"key":"1925_CR42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/cmi.2010.12","volume":"7","author":"L Pan","year":"2010","unstructured":"Pan L, Pan H, Jiang H, Du J, Wang X, Huang B et al (2010) HDAC4 inhibits the transcriptional activation of mda-7\/IL-24 induced by Sp1. Cell Mol Immunol 7:221","journal-title":"Cell Mol Immunol"},{"key":"1925_CR43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12967-015-0753-0","volume":"14","author":"J Liu","year":"2016","unstructured":"Liu J, Gu J, Feng Z, Yang Y, Zhu N, Lu W et al (2016) Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells. J Transl Med 14:7","journal-title":"J Transl Med"},{"key":"1925_CR44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/epi.13.73","volume":"6","author":"Z Wang","year":"2014","unstructured":"Wang Z, Qin G, Zhao TC (2014) HDAC4: mechanism of regulation and biological functions. Epigenomics 6:139\u2013150","journal-title":"Epigenomics"},{"key":"1925_CR45","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","volume":"76","author":"A Krumm","year":"2016","unstructured":"Krumm A, Barckhausen C, K\u00fcc\u00fck P, Tomaszowski KH, Loquai C, Fahrer J et al (2016) Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2 triggered drug resistance. Cancer Res 76:3067\u20133077","journal-title":"Cancer Res"},{"issue":"18","key":"1925_CR46","doi-asserted-by":"crossref","first-page":"1800228","DOI":"10.1002\/mnfr.201800228","volume":"62","author":"Adaobi Okonkwo","year":"2018","unstructured":"Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde M et al (2018) Heterocyclic analogs of sulforaphane trigger DNA damage and impede DNA repair in colon cancer cells:Interplay of HATs and HDACs. Mol. Nutr. Food Res 1800228","journal-title":"Molecular Nutrition & Food Research"},{"key":"1925_CR47","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1535-7163.MCT-06-0494","volume":"6","author":"A Pledgie-Tracy","year":"2007","unstructured":"Pledgie-Tracy A, Sobolewski MD, Davidson NE (2007) Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 6:1013\u20131021","journal-title":"Mol Cancer Ther"},{"key":"1925_CR48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jprot.2017.01.013","volume":"156","author":"B Abbaoui","year":"2017","unstructured":"Abbaoui B, Telu KH, Lucas CR, Thomas-Ahner JM, Schwartz SJ, Clinton SK et al (2017) The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer. J Proteomics 156:94\u2013103","journal-title":"J Proteomics"},{"key":"1925_CR49","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1158\/1535-7163.MCT-09-1146","volume":"9","author":"S Batra","year":"2010","unstructured":"Batra S, Sahu RP, Kandala PK, Srivastava SK (2010) Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-\u03baB turnoff in human pancreatic carcinoma cells. Mol Cancer Ther 9:1596\u20131608","journal-title":"Mol Cancer Ther"},{"key":"1925_CR50","first-page":"375","volume":"33","author":"LG Wang","year":"2008","unstructured":"Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM et al (2008) De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol 33:375\u2013380","journal-title":"Int J Oncol"},{"key":"1925_CR51","first-page":"1225","volume":"26","author":"AA Beklemisheva","year":"2006","unstructured":"Beklemisheva AA, Fang Y, Feng J, Ma X, Dai W, Chiao JW (2006) Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells. Anticancer Res 26:1225\u20131230","journal-title":"Anticancer Res"},{"key":"1925_CR52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biopha.2015.11.007","volume":"78","author":"LL Jiang","year":"2016","unstructured":"Jiang LL, Zhou SJ, Zhang XM, Chen HQ, Liu W (2016) Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity. Biomed Pharmacother 78:74\u201380","journal-title":"Biomed Pharmacother"},{"key":"1925_CR53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1096\/fj.05-4785fje","volume":"20","author":"MC Myzak","year":"2006","unstructured":"Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH (2006) Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 20:506\u2013508","journal-title":"FASEB J"},{"key":"1925_CR54","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.140199597","volume":"97","author":"CM Grozinger","year":"2000","unstructured":"Grozinger CM, Schreiber SL (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natll Acad Sci USA 97:7835\u20137840","journal-title":"Proc Natll Acad Sci USA"},{"key":"1925_CR55","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/jid.2013.187","volume":"133","author":"G Yan","year":"2013","unstructured":"Yan G, Eller MS, Elm C, Larocca CA, Ryu B, Panova IP et al (2013) Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence and inhibits DNA damage response in melanoma cells. J Invest Dermatol 133:2444\u20132452","journal-title":"J Invest Dermatol"},{"key":"1925_CR56","first-page":"6231","volume":"62","author":"D Bandyopadhyay","year":"2002","unstructured":"Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE (2002) Down-regulation of p300\/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res 62:6231\u20136239","journal-title":"Cancer Res"},{"key":"1925_CR57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nsmb740","volume":"11","author":"PR Thompson","year":"2004","unstructured":"Thompson PR, Wang D, Wang L, Fulco M, Pediconi N, Zhang D et al (2004) Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol 11:308\u2013315","journal-title":"Nat Struct Mol Biol"},{"key":"1925_CR58","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.drudis.2009.06.008","volume":"14","author":"FJ Dekker","year":"2009","unstructured":"Dekker FJ, Haisma HJ (2009) Histone acetyl transferases as emerging drug targets. Drug Discov Today 14:942\u2013948","journal-title":"Drug Discov Today"},{"key":"1925_CR59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-014-2501-1","volume":"74","author":"C Xia","year":"2018","unstructured":"Xia C, Leon-Ferre R, Laux D, Deutsch J, Smith BJ, Frees M et al (2018) Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide). Cancer Chemother Pharmacol 74:691\u2013697","journal-title":"Cancer Chemother Pharmacol"},{"key":"1925_CR60","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/ijc.31199","volume":"142","author":"SJ Gallagher","year":"2018","unstructured":"Gallagher SJ, Gunatilake D, Beaumont KA, Sharp DM, Tiffen JC, Heinemann A et al (2018) HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma. Int J Cancer 142:1926\u20131937","journal-title":"Int J Cancer"},{"key":"1925_CR61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/CMR.0b013e328364c0ed","volume":"23","author":"DM Woods","year":"2013","unstructured":"Woods DM, Woan K, Cheng F, Wang H, Perez-Villarroel P, Lee C et al (2013) The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity. Melanoma Res 23:341\u2013348","journal-title":"Melanoma Res"},{"key":"1925_CR62","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/1871520611313050010","volume":"13","author":"M Kusio-Kobialka","year":"2013","unstructured":"Kusio-Kobialka M, dudka-Ruszkowska W, Ghizzoni M, Dekker FJ, Piwocka K (2013) Inhibition of PCAF by anacardic acid derivative leads to apoptosis and breaks resistance to DNA damage in BCR-ABL-expressing cells. Anticancer Agents Med Chem 13:762\u2013767","journal-title":"Anticancer Agents Med Chem"},{"key":"1925_CR63","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.febslet.2006.06.092","volume":"580","author":"Y Sun","year":"2006","unstructured":"Sun Y, Jiang X, Chen S, Price BD (2006) Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett 580:4353\u20134356","journal-title":"FEBS Lett"},{"key":"1925_CR64","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1016\/j.bmc.2010.06.089","volume":"18","author":"M Ghizzoni","year":"2010","unstructured":"Ghizzoni M, Boltjes A, Graaf CD, Haisma HJ, Dekker FJ (2010) Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative. Bioorg Med Chem 18:5826\u20135834","journal-title":"Bioorg Med Chem"},{"key":"1925_CR65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ijc.26320","volume":"131","author":"O Alcazar","year":"2012","unstructured":"Alcazar O, Achberger S, Aldrich W, Hu Z, Negrotto S, Saunthararajah Y (2012) Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. Int J Cancer 131:18\u201329","journal-title":"Int J Cancer"},{"key":"1925_CR66","doi-asserted-by":"crossref","first-page":"89182","DOI":"10.18632\/oncotarget.21269","volume":"8","author":"Y Zakharia","year":"2017","unstructured":"Zakharia Y, Monga V, Swami U, Bossler AD, Freecmeier M, Frees M et al (2017) Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: a phase Ib study. Oncotarget 8:89182\u201389193","journal-title":"Oncotarget"},{"key":"1925_CR67","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.18632\/oncotarget.6681","volume":"7","author":"Y Akiyama","year":"2016","unstructured":"Akiyama Y, Koda Y, Byeon SJ, Shimada S, Nishikawaji T, Sakamoto A et al (2016) Reduced expression of SET7\/9, a histone mono-methyltransferase, is associated with gastric cancer progression. Oncotarget 7:3966","journal-title":"Oncotarget"},{"key":"1925_CR68","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2007.12.025","volume":"29","author":"JK Kurash","year":"2008","unstructured":"Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, Fan H et al (2008) Methylation of p53 by Set7\/9 mediates p53 acetylation and activity in vivo. Mol Cell 29:392\u2013400","journal-title":"Mol Cell"},{"key":"1925_CR69","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/acs.jmedchem.5b01732","volume":"59","author":"Y Takemoto","year":"2016","unstructured":"Takemoto Y, Ito A, Niwa H, Okamura M, Fujiwara T, Hirano T et al (2016) Identification of cyproheptadine as an inhibitor of SET domain containing lysine methyltransferase 7\/9 (Set7\/9) that regulates estrogen-dependent transcription. J Med Chem 59:3650\u20133660","journal-title":"J Med Chem"},{"key":"1925_CR70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tig.2003.09.007","volume":"19","author":"RJ Sims","year":"2003","unstructured":"Sims RJ, Nishioka K, Reinberg D (2003) Histone lysine methylation: a signature for chromatin function. Trends Genet 19:629\u2013639","journal-title":"Trends Genet"},{"key":"1925_CR71","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1073\/pnas.0401866101","volume":"101","author":"G Liang","year":"2004","unstructured":"Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT et al (2004) Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proc Natl Acad Sci USA 101:7357\u20137362","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-019-01925-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-019-01925-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-019-01925-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T14:15:58Z","timestamp":1583417758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-019-01925-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1925"],"URL":"https:\/\/doi.org\/10.1007\/s00394-019-01925-6","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}